Request Expert

Expert has combined his extensive expertise in molecular biology, immunology, molecular neuroscience and psychiatry, and cancer biology to develop a new avenue in the discovery of suitable molecular targets for complex treatment of neurodevelopmental disorders (e.g. ADHD). The new treatment strategies are designed to avoid adverse effects while taking care not only for managing the symptoms of the disorders but to result in their cure.

At the moment, some novel and exciting unpublished strategies for treatment of ADHD are considered by Expert. He obtained in vitro data supporting the idea that such treatment with naturally existing molecules will result in better development of children’s brain and possibly take care for removing the insomnia from which ADHD patients suffer. Expert is particularly interested in pursuing this new treatment strategy in animal models and in patients.

He has also consulted on applicability of different nanoparticles carriers of drugs in neorodevelopmental and other neurological disorders. This is a very important issue because in general all drugs and their carriers are tested for toxicity while not taking good care for their potential adverse effects by a complex assessment of physiological alterations that might occur.

He has combined his extensive expertise in molecular biology, immunology, molecular neuroscience and cancer biology to develop a new avenue in the discovery of suitable molecular targets for treatment of different tumour types which result specifically in killing the cancer cells while not having significant effect on non-malignant ones. These strategies have been tested both in vitro and in vivo showing a great promise. Some of the designed peptides have been filed for a patent application.

 Highly creative science leader with over 20 year experience in life and pharmaceutical sciences with particular emphasis on protein chemistry, immunotherapeutics, neuroscience/molecular psychiatry, working for organisations in Europe, North America and Middle East, focused on innovation and development of new therapeutics.
 Outstanding manager with unique profile, combining strong technical and teaching/training expertise, innovatively leading multi-cultural teams to deliver growth solutions.
 A proven track record in discovery of new therapeutic targets and development of new treatments.
 Influencing and growing life science publishing business and implementing a consumer-focused approach.

CORE QUALIFICATIONS & STRENGTHS

 Effective and innovative project and people management
 Strategic agility, project planning and budgeting
 Product development: discovery of new therapeutic targets and drug development
KEY ACHIEVEMENTS
PROJECT MANAGEMENT
Led and successfully completed a number of projects focused on:
 Design and assessment of oral formulations of therapeutic antibodies for treatment of infections and disorders of the gastrointestinal tract
 Signalling/molecular mechanisms underlying inflammatory responses in neuropsychiatric disorders and identification of suitable therapeutic targets for drug development
 Design of peptide adjuvants for targeted sensitisation of certain tumours to immunoclearance
 Currently organizing clinical trial


Consulted on interrelationship between complement system and clock genes in ADHD as a strategy for treatment of ADHD patients.He consulted on biomarkers for the response to drug treatment of major depression, signalling/molecular mechanisms underlying responses in major depression and identification of suitable therapeutic targets for drug development.Consulted on different nanoparticles designed as drug carriers in their applicability for treatment of psychiatric disorders without compromising neurogenesis and neurodevelopment.Consulted on methods employed in pharmaceutical and cosmetic industries, and academic research for development of robotised testing platforms.Consulting on continuous increase in reputation and sales of periodicals.